Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Oral Solid Dosage Contract Manufacturing Market Report 2024

Oral Solid Dosage Contract Manufacturing Global Market Report 2024 – By Product Type (Tablets, Capsules, Powders, Granules, Other Product Types ), By Service (Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications ), By Therapeutic Area (Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas ), By End User (Large Size Companies, Medium And Small Size Companies ) – Market Size, Trends, And Global Forecast 2024-2033

Oral Solid Dosage Contract Manufacturing Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : July 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Oral Solid Dosage Contract Manufacturing Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Oral Solid Dosage Contract Manufacturing Market Definition And Segments

Oral solid dosage contract manufacturing refers to outsourcing the production of oral solid dosage forms of pharmaceuticals to third-party manufacturers. This outsourcing strategy allows pharmaceutical companies to focus on their core activities, such as research, development, and marketing, while leveraging the expertise and capabilities of contract manufacturing organizations (CMO) to efficiently produce high-quality oral solid dosage pharmaceuticals.

The main product types of oral solid dosage contract manufacturing are tablets, capsules, powders, granules and other product types. A tablet is a small, solid mass of medicine containing an active drug and excipients. The services are drug product development, fill finish product manufacturing, API manufacturing, packaging and labelling and other applications. The therapeutic areas are oncology, cardiovascular diseases, metabolic disorders, neurological disorders, infectious diseases, gastrointestinal diseases and other therapeutic areas. The end users are large size companies and medium and small size companies.

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

The oral solid dosage contract manufacturing market size has grown strongly in recent years. It will grow from $36.70 billion in 2023 to $39.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the growing global population, prevalence of chronic diseases, and rise in focus on research and development.

The oral solid dosage contract manufacturing market size is expected to see strong growth in the next few years. It will grow to $52.94 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing outsourcing by pharmaceutical companies, advancements in drug delivery technology, and increasing drug development activities. Major trends in the forecast period include advancements in drug delivery technology, integration of 3D printing, and advancements in controlled-release technologies.

Increasing Demand For Generic Drugs Fuels Growth In The Oral Solid Dosage Contract Manufacturing Market

The increase in demand for generic drugs is expected to propel the growth of the oral solid dosage contract manufacturing market going forward. Generic drugs are medications that are bioequivalent to brand-name drugs in dosage, strength, safety, performance, quality, and intended use. The rising demand for generic drugs is attributed to patent expirations, cost containment efforts, regulatory incentives, and expanding access to healthcare. Oral solid dosage contract manufacturing significantly aids the production and distribution of generic drugs by leveraging the capabilities of contract manufacturers to enhance their operational efficiency, reduce costs, ensure high-quality production, and bring their products to market more swiftly and effectively. For instance, in 2022, according to the Food and Drug Administration, a US-based federal agency, it is estimated that 91% of all prescriptions in the USA were filled with generic drugs, with more than 32,000 generic drugs approved by the FDA (Food and Drug Administration). Therefore, the demand for generic drugs drives the growth of the oral solid dosage contract manufacturing market.

Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

Companies In Oral Solid Dosage Contract Manufacturing Market Focus On Innovative Solutions To Stay Competitive

Major companies operating in the oral solid dosage contract manufacturing market are focused on developing innovative solutions, such as continuous manufacturing lines, to sustain their position in the market. A continuous manufacturing line refers to a production facility or system that utilizes continuous manufacturing processes to produce pharmaceuticals or other products. For instance, in January 2023, WuXi STA, a China-based pharmaceutical company, launched its first continuous manufacturing line for oral solid pharmaceutical products. This cutting-edge facility marks a significant advancement in pharmaceutical production, leveraging continuous manufacturing principles to enhance efficiency, quality, and flexibility in drug manufacturing processes. This agility streamlines production timelines and reduces downtime, ultimately accelerating the delivery of vital medications to patients.

Catalent Acquires Metrics Contract Services To Enhance Oral Solid Dosage Capabilities

In August 2022, Catalent Inc., a US-based pharmaceutical company, acquired Metrics Contract Services for $475 million. With the acquisition, Catalent aims to expand its capabilities in developing and manufacturing oral solid dosage forms. Metrics Contract Services is a US-based full-service contract development and manufacturing organization (CDMO) specializing in oral dosage forms.

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral solid dosage contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral solid dosage contract manufacturing market consists of revenues earned by entities by providing services such as formulation development, analytical and stability testing, and quality assurance and control. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral solid dosage contract manufacturing market also consists of sales of orally disintegrating tablets (ODTS), lozenges, and chewing gums. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The oral solid dosage contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides oral solid dosage contract manufacturing market statistics, including oral solid dosage contract manufacturing industry global market size, regional shares, competitors with a oral solid dosage contract manufacturing market share, detailed oral solid dosage contract manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the oral solid dosage contract manufacturing industry. This oral solid dosage contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Oral Solid Dosage Contract Manufacturing Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $39.39 billion
Revenue Forecast In 2033 $52.94 billion
Growth Rate CAGR of 7.7% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Oral Solid Dosage Contract Manufacturing Market Characteristics

    3. Oral Solid Dosage Contract Manufacturing Market Trends And Strategies

    4. Oral Solid Dosage Contract Manufacturing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Oral Solid Dosage Contract Manufacturing Market Size and Growth

    5.1. Global Oral Solid Dosage Contract Manufacturing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Oral Solid Dosage Contract Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Oral Solid Dosage Contract Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Oral Solid Dosage Contract Manufacturing Market Segmentation

    6.1. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Tablets

    Capsules

    Powders

    Granules

    Other Product Types

    6.2. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Drug Product Development

    Fill Finish Product Manufacturing

    Active Pharmaceutical Ingredient (API) Manufacturing

    Packaging And Labelling

    Other Applications

    6.3. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oncology

    Cardiovascular Diseases

    Metabolic Disorders

    Neurological Disorders

    Infectious Diseases

    Gastrointestinal Diseases

    Other Therapeutic Areas

    6.4. Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Large Size Companies

    Medium And Small Size Companies

    7. Oral Solid Dosage Contract Manufacturing Market Regional And Country Analysis

    7.1. Global Oral Solid Dosage Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Oral Solid Dosage Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market

    8.1. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Oral Solid Dosage Contract Manufacturing Market

    9.1. China Oral Solid Dosage Contract Manufacturing Market Overview

    9.2. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Oral Solid Dosage Contract Manufacturing Market

    10.1. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Oral Solid Dosage Contract Manufacturing Market

    11.1. Japan Oral Solid Dosage Contract Manufacturing Market Overview

    11.2. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Oral Solid Dosage Contract Manufacturing Market

    12.1. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Oral Solid Dosage Contract Manufacturing Market

    13.1. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Oral Solid Dosage Contract Manufacturing Market

    14.1. South Korea Oral Solid Dosage Contract Manufacturing Market Overview

    14.2. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Oral Solid Dosage Contract Manufacturing Market

    15.1. Western Europe Oral Solid Dosage Contract Manufacturing Market Overview

    15.2. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Oral Solid Dosage Contract Manufacturing Market

    16.1. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Oral Solid Dosage Contract Manufacturing Market

    17.1. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Oral Solid Dosage Contract Manufacturing Market

    18.1. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Oral Solid Dosage Contract Manufacturing Market

    19.1. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Oral Solid Dosage Contract Manufacturing Market

    20.1. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Oral Solid Dosage Contract Manufacturing Market

    21.1. Eastern Europe Oral Solid Dosage Contract Manufacturing Market Overview

    21.2. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Oral Solid Dosage Contract Manufacturing Market

    22.1. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Oral Solid Dosage Contract Manufacturing Market

    23.1. North America Oral Solid Dosage Contract Manufacturing Market Overview

    23.2. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Oral Solid Dosage Contract Manufacturing Market

    24.1. USA Oral Solid Dosage Contract Manufacturing Market Overview

    24.2. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Oral Solid Dosage Contract Manufacturing Market

    25.1. Canada Oral Solid Dosage Contract Manufacturing Market Overview

    25.2. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Oral Solid Dosage Contract Manufacturing Market

    26.1. South America Oral Solid Dosage Contract Manufacturing Market Overview

    26.2. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Oral Solid Dosage Contract Manufacturing Market

    27.1. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Oral Solid Dosage Contract Manufacturing Market

    28.1. Middle East Oral Solid Dosage Contract Manufacturing Market Overview

    28.2. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Oral Solid Dosage Contract Manufacturing Market

    29.1. Africa Oral Solid Dosage Contract Manufacturing Market Overview

    29.2. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Oral Solid Dosage Contract Manufacturing Market Competitive Landscape And Company Profiles

    30.1. Oral Solid Dosage Contract Manufacturing Market Competitive Landscape

    30.2. Oral Solid Dosage Contract Manufacturing Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Takeda Pharmaceutical Company Limited

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Gilead Sciences Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Amgen Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Merck KGaA

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Oral Solid Dosage Contract Manufacturing Market Other Major And Innovative Companies

    31.1. Siemens Healthineers AG

    31.2. Evonik Industries AG

    31.3. Teva Pharmaceutical Industries Ltd.

    31.4. Lonza Group AG

    31.5. Catalent Inc.

    31.6. Patheon Pharma Services

    31.7. Fareva Holding SA

    31.8. Piramal Enterprises Limited

    31.9. Hetero Drugs Limited

    31.10. Siegfried Holding AG

    31.11. Recipharm AB

    31.12. Almac Group Limited

    31.13. Aenova Holding GmbH

    31.14. Jubilant Pharmova Limited

    31.15. Cambrex Corporation

    32. Global Oral Solid Dosage Contract Manufacturing Market Competitive Benchmarking

    33. Global Oral Solid Dosage Contract Manufacturing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Oral Solid Dosage Contract Manufacturing Market

    35. Oral Solid Dosage Contract Manufacturing Market Future Outlook and Potential Analysis

    35.1 Oral Solid Dosage Contract Manufacturing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Oral Solid Dosage Contract Manufacturing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Oral Solid Dosage Contract Manufacturing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Oral Solid Dosage Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Oral Solid Dosage Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 77: Gilead Sciences Inc. Financial Performance
  • Table 78: Amgen Inc. Financial Performance
  • Table 79: Merck KGaA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Oral Solid Dosage Contract Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Oral Solid Dosage Contract Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Oral Solid Dosage Contract Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Oral Solid Dosage Contract Manufacturing Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 77: Gilead Sciences Inc. Financial Performance
  • Figure 78: Amgen Inc. Financial Performance
  • Figure 79: Merck KGaA Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Electronic Contract Manufacturing and Design Services Global Market Report 2024 – By Type (Designing, Assembly, Manufacturing, Other Types), By Application (Consumer Electronics, Electronic Components, Computers & Peripherals, Industrial Electronics, Other Applications), By End User (Healthcare, Automotive, Industrial, Aerospace and Defense, IT and Telecom, Power and Energy, Consumer Electronics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Food Contract Manufacturing Global Market Report 2024 – By Services (Manufacturing Services, Packaging Services, Research and Development Services), By Manufacturing Process (Dry Blending, Spray Drying, Extrusion) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Medical Device Contract Manufacturing Global Market Report 2024 – By Device (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Endoscopy Devices, Ophthalmology Devices, Orthopedic Devices, Dental Devices, Other Devices), By Service (Device Development and Manufacturing Service, Quality Management Service, Assembly Service), By Application (Laparoscopy, Pulmonary, Urology, Gynecology, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Personal Care Contract Manufacturing Global Market Report 2024 – By Product Type (Skin Care, Hair Care, Make-Up And Cosmetics, Other Product Types), By Service Type (Research And Development And Formulation, Manufacturing, Packaging And Allied Services), By Formulation (Liquids, Creams, Lotions, Oils, Gels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Bakery Contract Manufacturing Global Market Report 2024 – By Product (Specialty And Nutritional Bakery Products, Traditional Bakery Products), By Service (Manufacturing, Packaging, Custom Formulation And R&D), By Application (Small And Medium Enterprises (SMEs), Large Enterprises) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Biopharmaceuticals Contract Manufacturing Global Market Report 2024 – By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars), By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC studies, Packaging), By Application (Clinical, Commercial) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2024 – By Product Type (Prefilled Syringes, Vials, Cartridges, Other Products), By Molecule Type (Large Molecules, Small Molecules), By End-User (Biopharmaceutical Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Vaccine Contract Manufacturing Global Market Report 2024 – By Service Type (Fill-Finish, Bulk Product), By Vaccine Type (Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines), By Process (Downstream, Upstream), By Scale Of Operation (Preclinical, Clinical, Commercial), By End-Use (Human Use, Veterinary) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the oral solid dosage contract manufacturing market?

Oral solid dosage contract manufacturing refers to outsourcing the production of oral solid dosage forms of pharmaceuticals to third-party manufacturers. This outsourcing strategy allows pharmaceutical companies to focus on their core activities, such as research, development, and marketing, while leveraging the expertise and capabilities of contract manufacturing organizations (CMO) to efficiently produce high-quality oral solid dosage pharmaceuticals. For further insights on the oral solid dosage contract manufacturing market, request a sample here

How will the oral solid dosage contract manufacturing market drivers and restraints affect the oral solid dosage contract manufacturing market dynamics? What forces will shape the oral solid dosage contract manufacturing industry going forward?

The oral solid dosage contract manufacturing market major growth driver - Increasing Demand For Generic Drugs Fuels Growth In The Oral Solid Dosage Contract Manufacturing Market. For further insights on the oral solid dosage contract manufacturing market, request a sample here

What is the forecast market size or the forecast market value of the oral solid dosage contract manufacturing market?

The oral solid dosage contract manufacturing market size has grown strongly in recent years. It will grow from $36.70 billion in 2023 to $39.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the growing global population, prevalence of chronic diseases, and rise in focus on research and development. The oral solid dosage contract manufacturing market size is expected to see strong growth in the next few years. It will grow to $52.94 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing outsourcing by pharmaceutical companies, advancements in drug delivery technology, and increasing drug development activities. Major trends in the forecast period include advancements in drug delivery technology, integration of 3D printing, and advancements in controlled-release technologies. For further insights on the oral solid dosage contract manufacturing market, request a sample here

How is the oral solid dosage contract manufacturing market segmented?

The oral solid dosage contract manufacturing market is segmented
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies For further insights on the oral solid dosage contract manufacturing market, request a sample here

Which region has the largest share of the oral solid dosage contract manufacturing market? What are the other regions covered in the report?

Asia Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the oral solid dosage contract manufacturing market, request a sample here.

Who are the major players in the oral solid dosage contract manufacturing market?

Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation For further insights on the oral solid dosage contract manufacturing market, request a sample here.

What are the key trends in the oral solid dosage contract manufacturing market?

Major trend in the oral solid dosage contract manufacturing market - Companies In Oral Solid Dosage Contract Manufacturing Market Focus On Innovative Solutions To Stay Competitive. For further insights on the oral solid dosage contract manufacturing marke request a sample here.

What are the major opportunities in the oral solid dosage contract manufacturing market? What are the strategies for the oral solid dosage contract manufacturing market?

For detailed insights on the major opportunities and strategies in the oral solid dosage contract manufacturing market, request a sample here.

How does the oral solid dosage contract manufacturing market relate to the overall economy and other similar markets?

For detailed insights on oral solid dosage contract manufacturing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the oral solid dosage contract manufacturing industry?

For detailed insights on the mergers and acquisitions in the oral solid dosage contract manufacturing industry, request a sample here.

What are the key dynamics influencing the oral solid dosage contract manufacturing market growth? SWOT analysis of the oral solid dosage contract manufacturing market.

For detailed insights on the key dynamics influencing the oral solid dosage contract manufacturing market growth and SWOT analysis of the oral solid dosage contract manufacturing industry, request a sample here.